Works matching IS 2230326X AND DT 2025 AND VI 15
Results: 3
Successful Treatment of Linear Psoriasis With the IL-17a-Antagonist Ixekizumab: A Case Report.
- Published in:
- 2025
- By:
- Publication type:
- Case Study
Breakthrough Psoriasis in Patients Receiving Biologicals.
- Published in:
- Psoriasis: Targets & Therapy, 2025, v. 15, p. 1, doi. 10.2147/PTT.S502382
- By:
- Publication type:
- Article
Shaping Treatment Expectation to Optimize Efficacy of Interleukin 17A Antagonist Secukinumab in Psoriasis Patients.
- Published in:
- Psoriasis: Targets & Therapy, 2025, v. 15, p. 9, doi. 10.2147/PTT.S486338
- By:
- Publication type:
- Article